Cargando…
Evaluation of the Octreotide Acetate Pen Injector and its Instructions for Use in a Formative Human Factors Study
INTRODUCTION: Octreotide acetate subcutaneous injection is indicated to treat acromegaly and the symptoms of carcinoid tumors and vasoactive intestinal peptide tumors (VIPomas). This formative human factors study assessed the octreotide acetate pen injector and accompanying instructions for use (IFU...
Autores principales: | Andre, Anthony, Squittieri, Nicholas, Patil, Satyashodhan B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189973/ https://www.ncbi.nlm.nih.gov/pubmed/33948925 http://dx.doi.org/10.1007/s12325-021-01739-1 |
Ejemplares similares
-
Evaluation of the Octreotide Acetate Pen Injector in a Formative Human Factors Study
por: Andre, Anthony, et al.
Publicado: (2021) -
Formative usability evaluation of a fixed-dose pen-injector platform device
por: Lange, Jakob, et al.
Publicado: (2018) -
Mistaking an Auto-injector for a Ballpoint Pen
por: Maeda, Atsuo, et al.
Publicado: (2020) -
Factors Affecting Performance of Insulin Pen Injector Technology: A
Narrative Review
por: Sparre, Thomas, et al.
Publicado: (2022) -
Evaluating the usability and safety of the semaglutide single‐dose pen‐injectors through summative (human factors) usability testing
por: Klonoff, David C, et al.
Publicado: (2020)